Want to see AU:CC5 full AI Analyst Report?
CC5 Stock Chart & Stats
AU$0.02
>-AU$0.01(-11.11%)
At close: 4:00 PM EDT
AU$0.02
>-AU$0.01(-11.11%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.04
Previous CloseN/A
Volume1.52M
Average Volume (3M)799.43K
Market Cap
AU$39.28M
Enterprise ValueAU$51.42M
Total Cash (Recent Filing)AU$1.70M
Total Debt (Recent Filing)AU$2.98M
Price to Earnings (P/E)―
Beta1.53
Next Earnings
Feb 25, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,182,255,100
10 Day Avg. Volume613,638
30 Day Avg. Volume799,435
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)6.27
Price to Sales (P/S)10.22
P/FCF Ratio-18.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)AU$4.00M
Bulls Say, Bears Say
Bulls Say
Moderate LeverageCurrent leverage appears moderate rather than excessively debt-funded, which gives the company some financial flexibility while it addresses operating weakness. A manageable debt burden can reduce interest-related pressure and preserve capacity for restructuring or selective investment over the next several quarters.
Prior Profitability BaseThe FY2025 results show that the business has previously generated positive net profit and strong gross margins, indicating that profitability is not entirely unproven. If operating execution improves, that prior performance provides a reference point for restoring earnings quality over the medium term.
Established Operating PlatformAn existing software-infrastructure operation with a defined workforce indicates an established platform rather than a purely pre-operational concept. That base may support focused execution and product continuity, although the recent financial deterioration means its ability to scale profitably remains unproven.
Bears Say
Revenue And Margin CollapseThe simultaneous decline in revenue and move to negative gross profit signal severe operating deterioration, with costs outpacing sales at the core business level. This weakens confidence in sustainable unit economics and suggests that restoring growth alone may not be enough without meaningful cost or pricing improvement.
Persistent Cash BurnNegative operating and free cash flow show that the business is consuming cash rather than funding operations and investment internally. If losses persist, the company may need continued external funding or spending reductions, limiting strategic flexibility and increasing financial risk over the next several quarters.
Balance-sheet And Earnings VolatilityHistorical negative equity and the rapid shift from profit to loss indicate that financial quality has been volatile rather than consistently supported by earnings power. This history makes current leverage less reassuring and raises concern about the durability of capital strength if operating losses continue.
LBT Innovations Limited News
CC5 FAQ
What was LBT Innovations Limited’s price range in the past 12 months?
LBT Innovations Limited lowest share price was AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is LBT Innovations Limited’s market cap?
LBT Innovations Limited’s market cap is AU$39.28M.
When is LBT Innovations Limited’s upcoming earnings report date?
LBT Innovations Limited’s upcoming earnings report date is Feb 25, 2027 which is in 142 days.
How were LBT Innovations Limited’s earnings last quarter?
LBT Innovations Limited released its earnings results on Aug 31, 2026. The company reported AU$0 earnings per share for the quarter.
Is LBT Innovations Limited overvalued?
According to Wall Street analysts LBT Innovations Limited’s price is currently Overvalued.
Does LBT Innovations Limited pay dividends?
LBT Innovations Limited does not currently pay dividends.
What is LBT Innovations Limited’s EPS estimate?
LBT Innovations Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LBT Innovations Limited have?
LBT Innovations Limited has 2,182,255,100 shares outstanding.
What happened to LBT Innovations Limited’s price movement after its last earnings report?
LBT Innovations Limited reported an EPS of AU$0 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of LBT Innovations Limited?
Currently, no hedge funds are holding shares in AU:CC5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
LBT Innovations Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:CC5 Sentiment 100%
Sector Average 63%
Sector Average 63%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.57%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
25.80%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
LBT Innovations Limited
Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
Technical Analysis
Senetas Corporation Limited
―
QuickFee Ltd.
―
Peppermint Innovation Limited
―
Sovereign Cloud Holdings Ltd.
―
HSC Technology Group Ltd.
―